Liang Gu
Chief Tech/Sci/R&D Officer at QuantumPharm, Inc.
Profile
Liang Gu is currently the Chief Technology Officer at QuantumPharm, Inc. He previously worked as the Associate Director-Development Planning at Shanghai Genomics, Inc. from 2007 to 2009.
From 2013 to 2015, he was an Associate at Yale University.
Dr. Gu then served as the Vice President-Research & Development at Sangfor Technologies, Inc. from 2015 to 2022.
He obtained his doctorate degree from Peking University in 2011.
Liang Gu active positions
| Companies | Position | Start |
|---|---|---|
QuantumPharm, Inc.
 QuantumPharm, Inc. BiotechnologyHealth Technology QuantumPharm, Inc. operates as a holding company with interests in drug research and development services. It engages in the business relating to drug discovery solutions including one-stop drug discovery solutions and automated chemical synthesis services and intelligent automation services. The company was founded by Lai Li Ppeng, Ma Jian and Wen Shu Hao in 2015 and is headquartered in Shenzhen, China. | Chief Tech/Sci/R&D Officer | 31/07/2022 |
Former positions of Liang Gu
| Companies | Position | End |
|---|---|---|
| SANGFOR TECHNOLOGIES INC. | Chief Tech/Sci/R&D Officer | 30/06/2022 |
| Yale University | Corporate Officer/Principal | 31/01/2015 |
Shanghai Genomics, Inc.
 Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Corporate Officer/Principal | 30/04/2009 |
Training of Liang Gu
| Peking University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
 | Health Technology |
| SANGFOR TECHNOLOGIES INC. | Technology Services |
| Private companies | 1 |
|---|---|
Shanghai Genomics, Inc.
Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Health Technology |
- Stock Market
- Insiders
- Liang Gu
